Economist Mohamed El-Erian took to X (formerly Twitter) on Thursday morning with a question after Blue Owl Capital Inc (NYSE:OWL) permanently halted redemption at its retail private credit fund.“Is this a ‘canary-in-the-coalmine’ moment, similar to August 2007?” El-Erian wrote, citing a Financial Times report that Blue Owl “will permanently restrict investors from withdrawing their cash from its inaugural private retail debt fund.” The idiom references the historical mining practice of using caged canaries ...

Meta Platforms (NASDAQ:META) is reviving its previously shelved “Malibu 2” project, with plans to launch its debut smartwatch in 2026. The watch is anticipated to offer health tracking features and an integrated Meta AI assistant, The Information reported on Wednesday. The revival of this project marks a significant return for AI-powered wearables, particularly in the health and fitness industry. The report also indicated that Meta has roughly four augmented reality (AR) and mixed reality (MR) glasses under ...

Akamai Technologies, Inc. (NASDAQ:AKAM) will release earnings results for its fourth quarter, after the closing bell on Thursday, Feb. 19.Analysts expect the Cambridge, Massachusetts-based company to report quarterly earnings at $1.75 per share, up from $1.66 per share in the year-ago period. The consensus estimate for Akamai's quarterly revenue is $1.08 billion, versus $1.02 billion a year earlier, according to data from Benzinga Pro.On Dec. 17, Akamai partnered with Visa Inc. (NYSE:V) to enhance identity ...

Earnings Report - Akamai Technologies, Inc. is set to release its fourth-quarter earnings results on February 19, with analysts expecting earnings of $1.75 per share, an increase from $1.66 per share in the same period last year [1] - The consensus estimate for quarterly revenue is $1.08 billion, compared to $1.02 billion a year earlier [1] Partnership and Stock Performance - On December 17, Akamai partnered with Visa Inc. to enhance identity verification, user recognition, and security for agentic commerce [2] - Following this partnership, Akamai's shares increased by 0.8%, closing at $109.31 [2]

President Donald Trump claimed on Wednesday that his administration's aggressive tariff policies have sparked a "staggering" 78% reduction in the U.S. trade deficit, vowing the nation will soon achieve its first trade surplus in decades.A Milestone In Trade Policy?In an all-caps post on Truth Social, the President lauded the impact of his global “reciprocal tariffs,” which targeted over 100 countries starting in April 2025.Trump attributed the contraction directly to these duties, stating, "The United State ...

Carvana Co. (NYSE:CVNA) shares slipped in premarket trading on Thursday as investors weighed fresh earnings details and cost pressures.The online used-vehicle retailer delivered stronger revenue than expected, yet mounting operational expenses and short-seller scrutiny shaped early sentiment around the stock.Quarterly PerformanceCarvana posted fourth-quarter revenue of nearly $5.6 billion, surpassing analyst projections that tracked closer to $5.26 billion. The company also disclosed earnings of $4.22 per s ...

Two long and one inverse fund continue Tradr's tradition of launching first-to-market strategiesNEW YORK, Feb. 19, 2026 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched three new leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver either two times the inverse (-200%) or two times long (200%) the daily performance of a specific underlying stock. All three ETFs are first-to-market strategies.The following ETFs are e ...

Zinger Key Point:MTX240's mechanistic novelty may give it a long-awaited edge in treatments for gastrointestinal stromal tumors (GIST)Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) , a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with an increasing focus on products to treat or prevent gastrointestinal cancers, has added a new phase 1-ready candidate to its portfolio, this time to target gastrointestinal stromal tumors, or GIST. MTX240's ...

The U.S. State Department is reportedly developing an online portal to provide access to content banned by European and other governments.The portal aims to bypass censorship by granting access to restricted content, including purported hate speech and terrorist propaganda. The site, set to launch at “freedom.gov,” is led by Undersecretary for Public Diplomacy Sarah Rogers, Reuters reported on Thursday.Officials had explored adding a virtual private network (VPN) feature to make users' traffic appear as if ...

Core Viewpoint - The health care sector has several oversold stocks that present potential buying opportunities for undervalued companies [1]. Group 1: Oversold Stocks - The Relative Strength Index (RSI) is a momentum indicator that helps traders assess stock performance, with an RSI below 30 indicating that a stock is typically considered oversold [1]. - A list of major oversold stocks in the health care sector includes companies with an RSI near or below 30 [2]. Group 2: Company Specifics - Schrodinger Inc (NASDAQ:SDGR) has an RSI value of 29.9, with its stock price falling approximately 28% over the past month, reaching a 52-week low of $11.15 [3]. - On February 18, Schrodinger reported inducement grants under Nasdaq Listing Rule 5635(c)(4) [3]. - Schrodinger's shares rose by 1.6% to close at $11.81 on Wednesday, with an Edge Stock Rating momentum score of 2.78 [3].